AU6703894A - Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes - Google Patents
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymesInfo
- Publication number
- AU6703894A AU6703894A AU67038/94A AU6703894A AU6703894A AU 6703894 A AU6703894 A AU 6703894A AU 67038/94 A AU67038/94 A AU 67038/94A AU 6703894 A AU6703894 A AU 6703894A AU 6703894 A AU6703894 A AU 6703894A
- Authority
- AU
- Australia
- Prior art keywords
- amidino
- trypsin
- enzymes
- boronic acid
- acid inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 150000001642 boronic acid derivatives Chemical class 0.000 title 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 title 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000001810 trypsinlike Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5283593A | 1993-04-27 | 1993-04-27 | |
US052835 | 1993-04-27 | ||
US20405594A | 1994-03-02 | 1994-03-02 | |
US204055 | 1994-03-02 | ||
PCT/US1994/004058 WO1994025049A1 (en) | 1993-04-27 | 1994-04-21 | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6703894A true AU6703894A (en) | 1994-11-21 |
Family
ID=26731141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU67038/94A Abandoned AU6703894A (en) | 1993-04-27 | 1994-04-21 | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0696199A4 (en) |
JP (1) | JPH08509723A (en) |
AU (1) | AU6703894A (en) |
CA (1) | CA2161216A1 (en) |
IL (1) | IL109319A0 (en) |
TW (1) | TW286318B (en) |
WO (1) | WO1994025049A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
US5561146A (en) * | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
FR2721611B1 (en) * | 1994-06-22 | 1996-09-27 | Adir | New peptide derivatives of boronic acid, their process of preparation and the pharmaceutical compositions which contain them. |
EP0846682B9 (en) | 1995-07-26 | 2003-05-14 | Mitsubishi Chemical Corporation | Penicillaminamide derivatives |
FR2739858B1 (en) * | 1995-10-11 | 1997-11-14 | Synthelabo | N-SULFONYL- AND N-SULFAMOYLPEPTIDYLPROLINAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
US6649593B1 (en) | 1999-10-13 | 2003-11-18 | Tularik Inc. | Modulators of SREBP processing |
BR0210112A (en) | 2001-05-30 | 2004-06-08 | Novartis Ag | 2 - {[n- (2-Amino-3- (heteroaryl or aryl) propionyl) -aminoacyl] -amino} -alkylboronic acid derivatives |
EP1466917A1 (en) | 2002-09-09 | 2004-10-13 | Trigen Limited | Method for making peptide boronic acids and acids obtainable thereby |
US7371729B2 (en) | 2002-09-09 | 2008-05-13 | Trigen Limited | Boronic acid salts useful in parenteral formulations |
US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
RU2353619C2 (en) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Novel compounds possessing anticoagulant function, based on them pharmaceutical compositions for treatment of thrombotic conditions and plasma-substituting solution for correction of hypercoagulation disorders in hemodilution |
RU2354647C2 (en) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | New compounds with thrombin inhibiting function, and based pharmaceutical compositions |
NZ600786A (en) | 2009-12-22 | 2013-12-20 | Cephalon Inc | Proteasome inhibitors and processes for their preparation, purification and use |
BR112018076614A2 (en) | 2016-06-21 | 2019-04-02 | Orion Ophthalmology LLC | heterocyclic prolinamide derivatives |
EP3472151A4 (en) | 2016-06-21 | 2020-03-04 | Orion Ophthalmology LLC | Carbocyclic prolinamide derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4499082A (en) * | 1983-12-05 | 1985-02-12 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid peptides |
US4537773A (en) * | 1983-12-05 | 1985-08-27 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid derivatives |
GB9024129D0 (en) * | 1990-11-06 | 1990-12-19 | Thrombosis Research Trust | Inhibitors and substrates of thrombin |
IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
-
1994
- 1994-04-13 IL IL10931994A patent/IL109319A0/en unknown
- 1994-04-21 WO PCT/US1994/004058 patent/WO1994025049A1/en not_active Application Discontinuation
- 1994-04-21 JP JP6524316A patent/JPH08509723A/en active Pending
- 1994-04-21 AU AU67038/94A patent/AU6703894A/en not_active Abandoned
- 1994-04-21 CA CA002161216A patent/CA2161216A1/en not_active Abandoned
- 1994-04-21 EP EP94914776A patent/EP0696199A4/en not_active Withdrawn
- 1994-05-07 TW TW083104198A patent/TW286318B/zh active
Also Published As
Publication number | Publication date |
---|---|
IL109319A0 (en) | 1994-07-31 |
TW286318B (en) | 1996-09-21 |
EP0696199A1 (en) | 1996-02-14 |
JPH08509723A (en) | 1996-10-15 |
WO1994025049A1 (en) | 1994-11-10 |
EP0696199A4 (en) | 1997-06-25 |
CA2161216A1 (en) | 1994-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3967195A (en) | Amidino and guanidino substituted inhibitors of trypsin-like enzymes | |
AU7922694A (en) | Dipeptide boronic acid inhibitors of trypsin-like enzymes | |
AU6703894A (en) | Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes | |
AU4640496A (en) | Boronic acid and ester inhibitors of thrombin | |
AU2162095A (en) | Modified guanidino and amidino thrombin inhibitors | |
AU7966494A (en) | Electrophilic peptide analogs as inhibitors of trypsin-like enzymes | |
AU1733288A (en) | Peptide boronic acid inhibitors of trypsin-like proteases | |
AU6897094A (en) | Identification and use of protease inhibitors | |
AU5533094A (en) | Enzyme inhibitors | |
AU5665396A (en) | Novel hydroxamic acid and amino-carboxylate compounds as met alloprotease and tnf inhibitors | |
AU4422096A (en) | Hydroxamic acid-containing inhibitors of matrix metalloproteases | |
AU8140898A (en) | Inhibitors of beta-lactamases and uses therefor | |
AU5493598A (en) | N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases | |
AU4980697A (en) | Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors | |
PL313871A1 (en) | Inhibitors of hiv protease | |
AU6955394A (en) | Vascularization inhibitor and novel compound | |
AU1515295A (en) | Inhibitors of urokinase plasminogen activator | |
AU584502B2 (en) | Phenylalanine derivatives and proteinase inhibitor | |
AU5556396A (en) | Hydroxamic and carboxylic acids as metalloprotease inhibitor s | |
AU5128793A (en) | N-(acylaminomethyl)glutaryl amino acids and their use as dual inhibitors of neutral endopeptidase and angiotensin converting enzyme | |
AU4077193A (en) | Alpha-aminoboronic acid peptides and their use as elastase inhibitors | |
AU7270794A (en) | Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors | |
HUP9802764A3 (en) | Guanidino protease inhibitors | |
AU5812294A (en) | Combination of angiotensin converting enzyme inhibitors and aii antagonists | |
AU6448794A (en) | Boronic acid and ester inhibitors of thrombin |